EARNINGS & TRADING: Nexus Infrastructure first-half loss narrows
The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 0.23p on 21-05-2026 at 16:30:00 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.24p |
| Sell | 0.22p |
| Last Trade: | Buy 540,000.00 at 0.235p |
| Day's Volume: | 990,000 |
| Last Close: | 0.23p |
| Open: | 0.23p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.23p - 0.23p |
| 52wk Range: | 0.18p - 0.286p |
| Market Capitalisation: | £4.94m |
| VWAP: | 0.229318p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 540,000 | 0.235p | Ordinary |
14:08:16 - 21-May-26 |
| Sell* | 450,000 | 0.2225p | Ordinary |
09:37:30 - 21-May-26 |
| Sell* | 451,232 | 0.2225p | Ordinary |
13:15:36 - 20-May-26 |
| Sell* | 200,000 | 0.23p | Ordinary |
10:45:34 - 20-May-26 |
| Sell* | 750,000 | 0.23p | Ordinary |
09:25:34 - 20-May-26 |
| Sell* | 100,000 | 0.23p | Ordinary |
16:29:05 - 19-May-26 |
| Buy* | 245,000 | 0.24p | Ordinary |
16:27:05 - 19-May-26 |
| Buy* | 79,377 | 0.24p | Ordinary |
13:57:27 - 19-May-26 |
| Sell* | 125,441 | 0.23p | Ordinary |
10:15:56 - 19-May-26 |
| Buy* | 1,591 | 0.24p | SI Trade |
09:16:13 - 19-May-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 15th May 2026 12:43 pm | RNS | Holding(s) in Company |
| 15th May 2026 7:00 am | RNS | Holding(s) in Company |
| 14th May 2026 7:00 am | RNS | Positive Ox-1 tox data in addiction programme |
| 21st Apr 2026 7:00 am | RNS-R | Investor Webinar |
| 20th Apr 2026 7:00 am | RNS | Successful GMP Manufacture Advances Ox-1 to Clinic |
| 16th Apr 2026 7:00 am | RNS | New Manufacturing Process Patent for Ox-1 |
| 14th Apr 2026 7:00 am | RNS | Non-Binding Proposal to Acquire TheraCryf’s Assets |
| 23rd Mar 2026 7:00 am | RNS | Ox-1 Programme Advances to Final Toxicology Study |
| 26th Jan 2026 7:00 am | RNS | Ox-1 Addiction Programme Update |
| 5th Jan 2026 7:00 am | RNS | Key Ox-1 milestone & notice of investor webinar |